These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11224099)

  • 1. Acute opioid administration effects on sensory and motor function in baboons: buprenorphine, morphine, and naloxone.
    Spear DJ; Hienz RD; Brady JV
    Behav Pharmacol; 1992 Feb; 3(1):31-42. PubMed ID: 11224099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptual and motor effects of morphine and buprenorphine in baboons.
    Hienz RD; Zarcone TJ; Brady JV
    Pharmacol Biochem Behav; 2001; 69(1-2):305-13. PubMed ID: 11420099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of d-methamphetamine on auditory and visual reaction times and detection thresholds in the baboon.
    Hienz RD; Lukas SE; Brady JV
    Psychopharmacology (Berl); 1985; 85(4):476-82. PubMed ID: 3927343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
    Shannon HE; Cone EJ; Gorodetzky CW
    J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of pentobarbital upon auditory and visual thresholds in the baboon.
    Hienz RD; Lukas SE; Brady JV
    Pharmacol Biochem Behav; 1981 Nov; 15(5):799-805. PubMed ID: 7312915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
    Fudala PJ; Yu E; Macfadden W; Boardman C; Chiang CN
    Drug Alcohol Depend; 1998 Mar; 50(1):1-8. PubMed ID: 9589267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of enhanced sensitivity to behavioral effects of naloxone induced by narcotic agonists in rats.
    Jain R; Ray R
    Indian J Physiol Pharmacol; 2003 Oct; 47(4):407-14. PubMed ID: 15266952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine.
    Zamani N; Hassanian-Moghaddam H; Bayat AH; Haghparast A; Shadnia S; Rahimi M; Hashemi Demaneh B; Assar N
    Toxicol Lett; 2015 Feb; 232(3):590-4. PubMed ID: 25510513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
    Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of buprenorphine on shock titration in squirrel monkeys.
    Dykstra LA
    J Pharmacol Exp Ther; 1985 Oct; 235(1):20-5. PubMed ID: 4045722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation.
    van Wolfswinkel L; van Ree JM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):84-92. PubMed ID: 4047179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine.
    Sarton E; Teppema L; Dahan A
    Adv Exp Med Biol; 2008; 605():486-91. PubMed ID: 18085322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of a nociceptive reaction by opioid antagonists in mice.
    Jacob JJ; Ramabadran K
    Br J Pharmacol; 1978 Sep; 64(1):91-8. PubMed ID: 698486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diazepam and triazolam on auditory and visual thresholds and reaction times in the baboon.
    Lukas SE; Hienz RD; Brady JV
    Psychopharmacology (Berl); 1985; 87(2):167-72. PubMed ID: 3931141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
    Pitts RC; Allen RM; Walker EA; Dykstra LA
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of buprenorphine/naloxone in opioid-dependent humans.
    Stoller KB; Bigelow GE; Walsh SL; Strain EC
    Psychopharmacology (Berl); 2001 Mar; 154(3):230-42. PubMed ID: 11351930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
    Paronis CA; Holtzman SG
    Psychopharmacology (Berl); 1994 May; 114(4):601-10. PubMed ID: 7855222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.